Login / Signup

Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial.

Yasmine HoydonckxMandeep SinghIan GilronJames KhanSamer NarouzeAlbert DahanKathryn CurtisXingshan CaoJamal KaraAnuj Bhatia
Published in: Trials (2023)
ClinicalTrials.gov NCT05306899. Registered on April 1, 2022.
Keyphrases
  • study protocol
  • randomized controlled trial
  • phase iii
  • phase ii
  • clinical trial
  • open label
  • physical activity
  • high dose
  • double blind
  • pain management
  • systematic review
  • cross sectional
  • low dose